Skip to main content

UBS Group AG

Position in RVPH — Reviva Pharmaceuticals Holdings, Inc.

CIK 1610520 ZURICH, V8

Position in RVPH

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,844
-$96,443 QoQ
Shares Held
5,269
-98.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RVPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in RVPH

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $0 0
2026-03-31 $3,844 5,269
2025-12-31 $100,287 359,455
2025-06-30 $76 200
2025-03-31 $213,213 223,541
2024-09-30 $3,330 2,313
2024-06-30 $169,523 132,440
2024-03-31 $30,614 8,099
2021-12-31 $5,675 1,964
2021-09-30 $6,422 1,578
2021-06-30 $9,880 2,033
2020-12-31 $14,953 1,710